Medicine and Dentistry
Cost-Effectiveness Analysis
100%
Life Cycle
100%
Health Care Cost
83%
Lifespan
33%
Quality Adjusted Life Year
33%
Health Technology
16%
Supportive Care
16%
Medical Device
16%
Surgical Technique
16%
End Stage Renal Disease
16%
Interferon
16%
Imatinib
16%
Chronic Myelogenous Leukemia
16%
Cinacalcet
16%
Device Procedure
16%
Pharmacology, Toxicology and Pharmaceutical Science
End Stage Renal Disease
100%
Interferon
100%
Imatinib
100%
Chronic Myeloid Leukemia
100%
Cinacalcet
100%
Economics, Econometrics and Finance
Life Cycle
100%
Price
100%
Cost-Effectiveness Analysis
100%
Willingness to Pay
16%
Mathematics
Life Cycle
100%
Mathematics
33%
Multiple Model
33%
Nonmathematical Language
33%